标普生物科技LOF(161127)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2022-06-30 | CLVS | Clovis Oncology Inc | 卖出 | 84.01 | 0.55% |
| 2022-06-30 | IBRX | ImmunityBio Inc | 卖出 | 83.05 | 0.55% |
| 2022-06-30 | ABBV | 艾伯维 | 卖出 | 75.7 | 0.5% |
| 2022-06-30 | AGEN | 艾吉纳斯 | 卖出 | 76.27 | 0.5% |
| 2022-06-30 | RAPT | RAPT Therapeutics Inc | 卖出 | 75.43 | 0.5% |
| 2022-06-30 | RXRX | Recursion Pharmaceuticals Inc-A | 卖出 | 75.61 | 0.5% |
| 2022-06-30 | DMTK | DermTech Inc | 卖出 | 71.56 | 0.47% |
| 2021-12-31 | HGEN | Humanigen Inc | 买入 | 214.11 | 2.39% |
| 2021-12-31 | BLUE | 蓝鸟生物 | 买入 | 204.23 | 2.28% |
| 2021-12-31 | MCRB | Seres Therapeutics Inc | 买入 | 199.67 | 2.23% |
| 2021-12-31 | DMTK | DermTech Inc | 买入 | 198.39 | 2.22% |
| 2021-12-31 | CCXI | ChemoCentryx Inc | 买入 | 198.14 | 2.21% |
| 2021-12-31 | AGIO | Agios Pharmaceuticals Inc | 买入 | 194.83 | 2.18% |
| 2021-12-31 | IBRX | ImmunityBio Inc | 买入 | 191.71 | 2.14% |
| 2021-12-31 | TGTX | TG Therapeutics Inc | 买入 | 191.31 | 2.14% |
| 2021-12-31 | FGEN | FibroGen Inc | 买入 | 185.24 | 2.07% |
| 2021-12-31 | CDNA | CareDx Inc | 买入 | 178.34 | 1.99% |
| 2021-12-31 | ACAD | 阿卡迪亚 | 买入 | 175.1 | 1.96% |
| 2021-12-31 | OCGN | Ocugen Inc | 买入 | 175.55 | 1.96% |
| 2021-12-31 | TPTX | Turning Point Therapeutics Inc | 买入 | 174.46 | 1.95% |
公告&资料
